Publication | Open Access

Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantation

Regenerative MedicineTransplantationXenotransplantationImmunologyCardiac XenotransplantationCardiac RegenerationClinical Cardiac XenotransplantationGraft SurvivalBiomedical EngineeringGraft RejectionMedicineCell TransplantationHeart Transplantation